Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Latopic
- Development stage
- Unknown
- Lead developer
- IBSS Biomed
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Topical
01
Overview
Latopic is a line of specialized dermatological products developed by Biomed-Lublin (IBSS Biomed) for the management of atopic dermatitis and dry, sensitive skin. The core active ingredient is SUPERNATANT BARIERA®, a proprietary complex consisting of metabolites derived from clinically tested probiotic strains of *Lactobacillus* sp. These metabolites exhibit antimicrobial properties, specifically inhibiting the growth of *Staphylococcus aureus*, a pathogen frequently associated with the exacerbation of atopic skin symptoms. By suppressing pathogenic bacteria and supporting the skin's natural barrier function, Latopic products help reduce inflammation, itching, and dryness. The range includes an active cream, body emulsion, and washing gel, all formulated for use in infants, children, and adults.
- Brand names
- Latopic
- Other names
- Latopic active creamLatopic active body emulsionLatopic face and body cream
Beyond the preview
Go deeper on Latopic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Latopic.